Plasma Levels of Metalloproteinase 3 (MMP-3) and Metalloproteinase 7 (MMP-7) as New Candidates for Tumor Biomarkers in Diagnostic of Breast Cancer Patients

• Published in: Journal of clinical medicine Vol. 12; no. 7; p. 2618
• Main Authors: Ławicki, Paweł, Malinowski, Paweł, Motyka, Joanna, Ławicki, Michał, Kicman, Aleksandra, Kulesza, Monika, Gacuta, Ewa, Guszczyn, Tomasz, Januszkiewicz, Marcin, Zbucka-Krętowska, Monika, Ławicki, Sławomir
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 30.03.2023; MDPI
• Subjects: Angiogenesis; Anticoagulants; Biomarkers; Breast cancer; Cancer therapies; Clinical medicine; Estrogens; Laboratories; Mammography; Metastasis; Pathogenesis; Patients; Plasma; Software; Statistical analysis; Ultrasonic imaging; Womens health; United States > US; luminal b her2-negative subtype; ca 15-3; mmp-3; breast cancer; fibroadenoma; mmp-7; luminal a subtype

Matrix metalloproteinases (MMPs) are a group of enzymes that mediate both physiological and pathological processes such as carcinogenesis. The role of matrix metalloproteinase-3 (MMP-3) and (MMP-7) in the pathogenesis of breast cancer (BC) has been demonstrated, suggesting that they may be considere...